Reata Pharmaceuticals, Inc. - (RETA)


Reata Pharmaceuticals, Inc. - (RETA)

$77.11 USD

1.20 (-1.53%)

Updated Aug 20 4:00pm

Add RETA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

RETA Daily Price Range
RETA 52-Week Price Range

RETA Stock Chart More Charts


RETA Price/Volume Stats

Current price $77.11
Prev. close $78.31
Day low $76.15
Day high $79.11
50-day MA $86.07
200-day MA $79.98
52-week high $104.53
52-week low $47.50
Volume 144,015
Avg. volume 226,760
Dividend yield N/A
Market Cap 2.32B

Reata Pharmaceuticals, Inc. - (RETA) Company Bio


Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on identifying, developing, and commercializing product candidates that modulate the activity of key regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with various serious or life-threatening diseases. The company was founded in 2002 and is based in Irving, Texas.





RETA News Stream


Event/Time News Detail
Loading, please wait...

RETA Social Stream


Loading social stream, please wait...

View Full RETA Social Stream

RETA Returns

1-mo -11.54%
3-mo -15.59%
6-mo -11.59%
1-year 3.18%
3-year 319.53%
5-year N/A
YTD 37.45%
2018 98.09%
2017 29.73%
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4858 seconds.